MARKET

FEMY

FEMY

FEMASYS INC
NASDAQ
0.3847
-0.0977
-20.25%
Opening 12:00 03/30 EDT
OPEN
0.4530
PREV CLOSE
0.4824
HIGH
0.4605
LOW
0.3305
VOLUME
2.39M
TURNOVER
--
52 WEEK HIGH
1.630
52 WEEK LOW
0.3067
MARKET CAP
22.89M
P/E (TTM)
-0.5344
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at FEMY last week (0323-0327)?
Weekly Report · 12h ago
Femasys announces special stockholder meeting; board recommends voting for proposals 1, 2 and 3
Reuters · 3d ago
Femasys files Form 3 initial beneficial ownership statement for Director Kenneth D. Eichenbaum
Reuters · 6d ago
Femasys management to meet virtually with Lake Street
TipRanks · 6d ago
Weekly Report: what happened at FEMY last week (0316-0320)?
Weekly Report · 03/23 09:27
Femasys Amends Financing Terms and Issues New Warrants
TipRanks · 03/20 21:51
FEMASYS INC - AMENDMENT REMOVES SHARE COMBINATION EVENT ADJUSTMENT IN NOTES AND WARRANTS EFFECTIVE DEC 31, 2025 - SEC FILING
Reuters · 03/20 21:18
Femasys issues 16,378,563 unregistered Series D-1 warrants at $0.58 exercise price
Reuters · 03/20 21:17
More
About FEMY
Femasys Inc. is a biomedical company. The Company is focused on addressing the unmet needs of women worldwide with a broad portfolio of in-office, accessible, and therapeutic and diagnostic solutions. The Company has two lead product candidates: FemBloc and FemaSeed. FemBloc is a permanent birth control solution in development. Its permanent birth control solution in development includes its FemBloc system, which features dual intrauterine directional delivery targeting both fallopian tubes with a degradable blended biopolymer. FemaSeed is an artificial insemination infertility treatment. Its artificial insemination solution in development includes its FemaSeed product candidate for artificial insemination, which features single intrauterine directional delivery. It also developed FemCerv, which is an endocervical tissue sampler for cervical cancer diagnosis; FemVue, which is a companion diagnostic for fallopian tube assessment; FemCath, which is an intrauterine catheter, and FemChec.

Webull offers Femasys Inc stock information, including NASDAQ: FEMY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FEMY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FEMY stock methods without spending real money on the virtual paper trading platform.